Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yan Pan, Lei Liu, Huijuan Yang, Weidong Chen, Zheng Chen & Jing Xu. (2022) Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway. Diabetes, Metabolic Syndrome and Obesity 15, pages 2479-2488.
Read now
Read now
Si Wen, Zhao-Hua Wang, Cong-Xiao Zhang, Ying Yang & Qiu-Ling Fan. (2020) Caspase-3 Promotes Diabetic Kidney Disease Through Gasdermin E-Mediated Progression to Secondary Necrosis During Apoptosis. Diabetes, Metabolic Syndrome and Obesity 13, pages 313-323.
Read now
Read now
Articles from other publishers (60)
Dimitris Kounatidis, Natalia Vallianou, Angelos Evangelopoulos, Ioannis Vlahodimitris, Eugenia Grivakou, Evangelia Kotsi, Krystalia Dimitriou, Alexandros Skourtis & Iordanis Mourouzis. (2023) SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?. Nutrients 15:10, pages 2294.
Crossref
Crossref
Qi Ke, Ashley Nicole Greenawalt, Veera Manukonda, Xingqi Ji & Roland Michael Tisch. (2023) The regulation of self-tolerance and the role of inflammasome molecules. Frontiers in Immunology 14.
Crossref
Crossref
Xuliang Zhang, Jiayu Du, Siming Huo, Bo Li, Jian Zhang, Miao Song, Bing Shao & Yanfei Li. (2023) Hexafluoropropylene oxide trimer acid causes fibrosis in mice liver via mitochondrial ROS/cGAS-STING/NLRP3-mediated pyroptosis. Food and Chemical Toxicology 174, pages 113706.
Crossref
Crossref
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, Qun Yu, Miao Zeng, Liding Bai, Lin Yang, Maojuan Guo, Xijuan Jiang & Jiali Gan. (2023) Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review). International Journal of Molecular Medicine 51:4.
Crossref
Crossref
Shen Lu, Yanrong Li, Zhaojun Qian, Tiesuo Zhao, Zhiwei Feng, Xiaogang Weng & Lili Yu. (2023) Role of the inflammasome in insulin resistance and type 2 diabetes mellitus. Frontiers in Immunology 14.
Crossref
Crossref
Gengzhen Huang, Yaodan Zhang, Yingying Zhang & Yuerong Ma. (2023) Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies. Biochemistry and Biophysics Reports 33, pages 101417.
Crossref
Crossref
Antonella La Russa, Danilo Lofaro, Alberto Montesanto, Daniele La Russa, Gianluigi Zaza, Simona Granata, Michele Di Dio, Raffaele Serra, Michele Andreucci, Renzo Bonofiglio & Anna Perri. (2023) Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease. International Journal of Molecular Sciences 24:4, pages 4184.
Crossref
Crossref
Xin Li, Tian-Kui Ma, Min Wang, Xiao-Dan Zhang, Tian-Yan Liu, Yue Liu, Zhao-Hui Huang, Yong-Hong Zhu, Shuang Zhang, Li Yin, Yan-Yan Xu, Hong Ding, Cong Liu, Hang Shi & Qiu-Ling Fan. (2023) YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway. Frontiers in Pharmacology 14.
Crossref
Crossref
M. Raucoules-Aimé & T. Thierry Nessan Ouattara. (2023) Gestione perioperatoria del paziente diabetico adulto. EMC - Anestesia-Rianimazione 28:1, pages 1-26.
Crossref
Crossref
M. Raucoules-Aimé & T. Thierry Nessan Ouattara. (2023) Tratamiento perioperatorio del paciente diabético adulto. EMC - Anestesia-Reanimación 49:1, pages 1-29.
Crossref
Crossref
Yunjiao Wang, Yanyang Li, Wanqin Zhang, Zhuo Yuan, Shichao Lv & Junping Zhang. (2022) NLRP3 Inflammasome: a Novel Insight into Heart Failure. Journal of Cardiovascular Translational Research 16:1, pages 166-176.
Crossref
Crossref
Jun Zhou, Shan Yan, Xu Guo, Yanguo Gao, Shiqi Chen, Xiaohan Li, Yonghong Zhang, Qibin Wang, Tao Zheng & Li Chen. (2023) Salidroside protects pancreatic β-cells against pyroptosis by regulating the NLRP3/GSDMD pathway in diabetic conditions. International Immunopharmacology 114, pages 109543.
Crossref
Crossref
Bo Li, Xuliang Zhang, Siming Huo, Jian Zhang, Jiayu Du, Bonan Xiao, Miao Song, Bing Shao & Yanfei Li. (2022) Aluminum activates NLRP3 inflammasome-mediated pyroptosis via reactive oxygen species to induce liver injury in mice. Chemico-Biological Interactions 368, pages 110229.
Crossref
Crossref
Kriti Kushwaha, Uma KabraRupal Dubey & Jeena Gupta. (2022) Diabetic Nephropathy: Pathogenesis to Cure. Current Drug Targets 23:15, pages 1418-1429.
Crossref
Crossref
Xuliang Zhang, Bo Li, Siming Huo, Jiayu Du, Jian Zhang, Miao Song, Yilong Cui & Yanfei Li. (2022) T-2 Toxin Induces Kidney Fibrosis via the mtROS-NLRP3-Wnt/β-Catenin Axis. Journal of Agricultural and Food Chemistry 70:42, pages 13765-13777.
Crossref
Crossref
Jiayi Wan, Dongwei Liu, Shaokang Pan, Sijie Zhou & Zhangsuo Liu. (2022) NLRP3-mediated pyroptosis in diabetic nephropathy. Frontiers in Pharmacology 13.
Crossref
Crossref
Yinhua Ni, Liujie Zheng, Sujie Nan, Lehui Ke, Zhengwei Fu & Juan Jin. (2022) Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota. Acta Biochimica et Biophysica Sinica 54:10, pages 1406-1420.
Crossref
Crossref
Junling Gu, Kang Geng, Man Guo, Wei Huang, Tingting Zhao, Xuling Li, You-Hua Xu & Yong Xu. (2022) Targeting Pyroptosis: New Insights into the Treatment of Diabetic Microvascular Complications. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-11.
Crossref
Crossref
Rebecca C. Coll, Kate Schroder & Pablo Pelegrín. (2022) NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends in Pharmacological Sciences 43:8, pages 653-668.
Crossref
Crossref
Bihao Liu, Dejuan Wang, Yiwen Cao, Jianjian Wu, Yuan Zhou, Wenjia Wu, Junbiao Wu, Jiuyao Zhou & Jianguang Qiu. (2022) MitoTEMPO protects against podocyte injury by inhibiting NLRP3 inflammasome via PINK1/Parkin pathway-mediated mitophagy. European Journal of Pharmacology 929, pages 175136.
Crossref
Crossref
Hao Li, Yanling Guan, Bo Liang, Peng Ding, Xin Hou, Wei Wei & Yang Ma. (2022) Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. European Journal of Pharmacology 928, pages 175091.
Crossref
Crossref
Chongbin Liu, Ming Yang, Li Li, Shilu Luo, Jinfei Yang, Chenrui Li, Huafeng Liu & Lin Sun. (2022) A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease. Frontiers in Physiology 13.
Crossref
Crossref
B. M. Williams, C. L. Cliff, K. Lee, P. E. Squires & C. E. Hills. (2022) The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy. Frontiers in Physiology 13.
Crossref
Crossref
Hong-Bao Tan, Qian Zhao & Li Chen. (2022) Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2. International Immunopharmacology 107, pages 108680.
Crossref
Crossref
Roberto Boi, Kerstin Ebefors, Marcus Henricsson, Jan Borén & Jenny Nyström. (2022) Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions. Scientific Reports 12:1.
Crossref
Crossref
Xinzhang Chen, Zhiheng Zhang, Meilun Shen, Xiangying Ma, Di Qiu, Siyao Li & Li Gao. (2022) Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats. Molecules 27:9, pages 2931.
Crossref
Crossref
Saba Bakhshi & Saeedeh Shamsi. (2022) MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes. International Immunopharmacology 106, pages 108595.
Crossref
Crossref
Carol M. Artlett. (2022) The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis. Biomolecules 12:5, pages 634.
Crossref
Crossref
Nathan H. Johnson, Robert W. Keane & Juan Pablo de Rivero Vaccari. (2022) Renal and Inflammatory Proteins as Biomarkers of Diabetic Kidney Disease and Lupus Nephritis. Oxidative Medicine and Cellular Longevity 2022, pages 1-11.
Crossref
Crossref
Yuqing Zhang, De Jin, Yingying Duan, Yuehong Zhang, Liyun Duan, Fengmei Lian & Xiaolin Tong. (2022) Bibliometric Analysis of Renal Fibrosis in Diabetic Kidney Disease From 1985 to 2020. Frontiers in Public Health 10.
Crossref
Crossref
Jakob A. Østergaard, Jay C. Jha, Arpeeta Sharma, Aozhi Dai, Judy S.Y. Choi, Judy B. de Haan, Mark E. Cooper & Karin Jandeleit-Dahm. (2022) Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease. Clinical Science 136:2, pages 167-180.
Crossref
Crossref
Chelsy L. Cliff, Bethany M. Williams, Christos E. Chadjichristos, Ulrik Mouritzen, Paul E. Squires & Claire E. Hills. (2022) Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes. International Journal of Molecular Sciences 23:2, pages 600.
Crossref
Crossref
Yaji Dai, Mingfei Guo, Lei Jiang & Jiarong Gao. (2022) Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy. Medicine 101:5, pages e28747.
Crossref
Crossref
Ning Li, Yuru Wang, Xinyue Wang, Na Sun & Yan-Hua Gong. (2022) Pathway network of pyroptosis and its potential inhibitors in acute kidney injury. Pharmacological Research 175, pages 106033.
Crossref
Crossref
Ara Aboolian, Sofia Urner, Michael Roden, Jay Chandra Jha & Karin Jandeleit-Dahm. 2022. From Obesity to Diabetes. From Obesity to Diabetes
269
307
.
Abdullah Al Mamun, Anjuman Ara Mimi, Yanqing Wu, Muhammad Zaeem, Md. Abdul Aziz, Suzia Aktar Suchi, Eman Alyafeai, Fahad Munir & Jian Xiao. (2021) Pyroptosis in diabetic nephropathy. Clinica Chimica Acta 523, pages 131-143.
Crossref
Crossref
Camila Barbosa Oliveira, Camilla Albertina Dantas Lima, Gisele Vajgel & Paula Sandrin-Garcia. (2021) The Role of NLRP3 Inflammasome in Lupus Nephritis. International Journal of Molecular Sciences 22:22, pages 12476.
Crossref
Crossref
Xu Chen, Dongxing Zhang, Yuping Li, Weixuan Wang, Weijian Bei & Jiao Guo. (2021) NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe?. Pharmacological Research 173, pages 105885.
Crossref
Crossref
Sanja Löb, Beate Ochmann, Zhi Ma, Theresa Vilsmaier, Christina Kuhn, Elisa Schmoeckel, Saskia-Laureen Herbert, Thomas Kolben, Achim Wöckel, Sven Mahner & Udo Jeschke. (2021) The role of Interleukin-18 in recurrent early pregnancy loss. Journal of Reproductive Immunology 148, pages 103432.
Crossref
Crossref
Linjuan Zhang, Mengmeng Jing & Quan Liu. (2021) Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes. Life Sciences 278, pages 119542.
Crossref
Crossref
Zhipeng Yan, Zhongwen Qi, Xiaoya Yang, Nan Ji, Yueyao Wang, Qi Shi, Meng Li, Junping Zhang & Yaping Zhu. (2021) The NLRP3 inflammasome: Multiple activation pathways and its role in primary cells during ventricular remodeling. Journal of Cellular Physiology 236:8, pages 5547-5563.
Crossref
Crossref
Wei Xiong, Xian-Fang Meng & Chun Zhang. (2021) NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update. Frontiers in Immunology 12.
Crossref
Crossref
Qin Qin, Guang Xu, Xiaoyan Zhan, Zhilei Wang, Yan Wang, Hongbin Liu, Xiaorong Hou, Wei Shi, Jianli Ma, Zhaofang Bai & Xiaohe Xiao. (2021) Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Molecular Immunology 135, pages 116-126.
Crossref
Crossref
Chi Teng Vong, Hisa Hui Ling Tseng, Peifen Yao, Hua Yu, Shengpeng Wang, Zhangfeng Zhong & Yitao Wang. (2021) Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases. Drug Discovery Today 26:6, pages 1394-1408.
Crossref
Crossref
C.M. Mosterd, M. Kanbay, B.J.H. van den Born, D.H. van Raalte & E. Rampanelli. (2021) Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression. Best Practice & Research Clinical Endocrinology & Metabolism 35:3, pages 101484.
Crossref
Crossref
Li Wen, Hongliu Yang, Liang Ma & Ping Fu. (2021) The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy. Molecular and Cellular Biochemistry 476:3, pages 1377-1386.
Crossref
Crossref
Shengfeng Wan, Shengkai Wan, Xiaojing Jiao, Huixia Cao, Yue Gu, Lei Yan, Yan Zheng, Peiyuan Niu & Fengmin Shao. (2021) Advances in understanding the innate immune‐associated diabetic kidney disease. The FASEB Journal 35:2.
Crossref
Crossref
Yupeng Jiang, Feifei Xie, Xin Lv, Shuting Wang, Xiaohua Liao, Yue Yu, Qin Dai, Yan Zhang, Jie Meng, Gaoyun Hu, Zhangzhe Peng & Lijian Tao. (2020) Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice. The FASEB Journal 35:1.
Crossref
Crossref
Maria Sebastian-Valverde, Henry Wu, Md Al Rahim, Roberto Sanchez, Kunal Kumar, Robert J. De Vita & Giulio Maria Pasinetti. (2021) Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes. Journal of Biological Chemistry 296, pages 100597.
Crossref
Crossref
Amelia Charlton, Jessica Garzarella, Karin A. M. Jandeleit-Dahm & Jay C. Jha. (2020) Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes. Biology 10:1, pages 18.
Crossref
Crossref
Zhuang-Zhuang Tang, Yu-Meng Zhang, Ting Zheng, Ting-Ting Huang, Teng-Fei Ma & Yao-Wu Liu. (2020) Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study. Phytomedicine 78, pages 153314.
Crossref
Crossref
Fen Zheng, Chao Ye, Guo-Wei Wan, Bing Zhou, Ying Tong, Jian-Zhen Lei, Qi Chen, Yue-Hua Li, Yu-Ming Kang & Guo-Qing Zhu. (2020) Interleukin-1β in hypothalamic paraventricular nucleus mediates excitatory renal reflex. Pflügers Archiv - European Journal of Physiology 472:11, pages 1577-1586.
Crossref
Crossref
Chetan Ram, Ankush Kumar Jha, Aparajita Ghosh, Shobhit Gairola, Abu Mohammad Syed, Upadhyayula Suryanarayana Murty, V.G.M. Naidu & Bidya Dhar Sahu. (2020) Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches. European Journal of Pharmacology 885, pages 173503.
Crossref
Crossref
Jakob Appel Østergaard, Mark Emmanuel Cooper & Karin Agnes Maria Jandeleit-Dahm. (2020) Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease. Journal of Nephrology 33:5, pages 917-929.
Crossref
Crossref
Jinwen Lin, Ao Cheng, Kai Cheng, Qingwei Deng, Shouzan Zhang, Zehao Lan, Weidong Wang & Jianghua Chen. (2020) New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease. International Journal of Molecular Sciences 21:19, pages 7057.
Crossref
Crossref
Yi Tan, Zhiguo Zhang, Chao Zheng, Kupper A. Wintergerst, Bradley B. Keller & Lu Cai. (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nature Reviews Cardiology 17:9, pages 585-607.
Crossref
Crossref
Stefano Menini, Carla Iacobini, Martina Vitale & Giuseppe Pugliese. (2020) The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. Cells 9:8, pages 1812.
Crossref
Crossref
Sandra Rayego-Mateos, José Luis Morgado-Pascual, Lucas Opazo-Ríos, Melania Guerrero-Hue, Cristina García-Caballero, Cristina Vázquez-Carballo, Sebastián Mas, Ana Belén Sanz, Carmen Herencia, Sergio Mezzano, Carmen Gómez-Guerrero, Juan Antonio Moreno & Jesús Egido. (2020) Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy. International Journal of Molecular Sciences 21:11, pages 3798.
Crossref
Crossref
Ming-Fei Guo, Ya-Ji Dai, Jia-Rong Gao & Pei-Jie Chen. (2020) Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology. Journal of Diabetes Research 2020, pages 1-13.
Crossref
Crossref
Yang Gyun Kim, Su-Mi Kim, Ki-Pyo Kim, Sang-Ho Lee & Ju-Young Moon. (2019) The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney. Cells 8:11, pages 1389.
Crossref
Crossref